Environmental, Social And Governance Report

Overview

The report describes Everest Medicines' 2022 ESG performance across its environmental and social operations. It presents a stakeholder-based materiality assessment covering 19 ESG topics and identifies five issues as most important. The Group reported 635.46 tonnes of GHG emissions, primarily from purchased electricity, and disclosed energy and water consumption. Its year-end workforce was 365 employees, while the report recorded zero work-related fatalities and one injury case during the Reporting Period.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services